AceView: Gene:XPOT, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
BI457849	brain, hypothalamus	XPOT.a	1 to 710	7 to 736		tiling clone,		713/757 (94 %)	44 diff (94.2 %id)
CX166551	human embryonic stem cells differentiated toan early endodermal cell type	XPOT.a	23 to 791	1 to 768				768/768 (100 %)	3 diff (99.7 %id)
CR979468	T-Lymphocytes	XPOT.a	23 to 942	1 to 921		tiling clone,		921/927 (99 %)	4 diff (99.6 %id)
DB131498	thymus	XPOT.a	85 to 633	2 to 550		capped		549/549 (100 %)	1 diff (99.9 %id)
DA093700	cerebellum	XPOT.a	102 to 671	2 to 571		capped		570/578 (98 %)	0 diff (100 %id)
DA313641	hippocampus	XPOT.a	102 to 641	2 to 541		capped		540/540 (100 %)	0 diff (100 %id)
DB083603	testis	XPOT.a	102 to 632	2 to 532		capped		531/531 (100 %)	1 diff (99.9 %id)
DB454090	testis	XPOT.a	103 to 589	1 to 487				487/488 (99 %)	7 diff (98.6 %id)
BQ215290	large cell carcinoma, lung	XPOT.a	103 to 917	1 to 817				817/879 (92 %)	8 diff (99.1 %id)
NM_007235.3		XPOT.a	103 to 3967	1 to 3865	exact	RefSeq, AAA		3865/3865 (100 %)	0 diff (100 %id)
DA188982	amygdala	XPOT.a	105 to 648	2 to 545		capped		544/544 (100 %)	0 diff (100 %id)
AU132928		XPOT.a	105 to 1018	2 to 923		capped		922/953 (96 %)	23 diff (97.6 %id)
DB226418	trachea	XPOT.a	105 to 660	2 to 557		capped		556/556 (100 %)	0 diff (100 %id)
DA856680	placenta	XPOT.a	106 to 671	2 to 567		capped		566/566 (100 %)	0 diff (100 %id)
BJ992747	hepatoblastoma	XPOT.a	111 to 511	1 to 402				402/404 (99 %)	3 diff (99.3 %id)
TI_44166772		XPOT.a	111 to 823	80 to 791				712/791 (90 %)	7 diff (99.2 %id)
DA092172	cerebellum	XPOT.a	112 to 635	2 to 526		capped		525/525 (100 %)	4 diff (99.3 %id)
DA115988	cerebellum	XPOT.a	112 to 692	2 to 582		capped		581/581 (100 %)	2 diff (99.7 %id)
DA245114	brain	XPOT.a	112 to 704	2 to 594		capped		593/593 (100 %)	1 diff (99.9 %id)
DA386554	thalamus	XPOT.a	112 to 706	2 to 596		capped		595/595 (100 %)	0 diff (100 %id)
DA410540	thalamus	XPOT.a	112 to 670	2 to 560		capped		559/559 (100 %)	0 diff (100 %id)
DA417731	thalamus	XPOT.a	112 to 671	2 to 562		capped		559/569 (98 %)	2 diff (99.7 %id)
DA457677	tongue, tumor tissue	XPOT.a	112 to 682	2 to 572		capped		571/571 (100 %)	0 diff (100 %id)
DB289330	uterus	XPOT.a	112 to 661	2 to 556		capped		555/555 (100 %)	5 diff (99.1 %id)
BP873599	embryonal kidney	XPOT.a	114 to 589	1 to 476				476/482 (98 %)	2 diff (99.6 %id)
BI548751	brain, hippocampus	XPOT.a	114 to 823	1 to 709				709/709 (100 %)	6 diff (99.2 %id)
DA103588	cerebellum	XPOT.a	117 to 660	2 to 545		capped		544/544 (100 %)	0 diff (100 %id)
DA810840	brain	XPOT.a	117 to 661	2 to 546		capped		545/545 (100 %)	0 diff (100 %id)
DB220662	trachea	XPOT.a	117 to 685	2 to 570		capped		569/569 (100 %)	0 diff (100 %id)
CN409165	embryonic stem cells, DMSO-treated H9 cellline	XPOT.a	122 to 885	1 to 765				765/765 (100 %)	5 diff (99.4 %id)
CN409161	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	128 to 807	12 to 691				680/691 (98 %)	6 diff (99.2 %id)
CN481709	eye	XPOT.a	128 to 735	1 to 608				608/608 (100 %)	0 diff (100 %id)
CB215702	normal endometrium, late proliferativephase, cycle day 13, uterus	XPOT.a	132 to 755	1 to 624				624/624 (100 %)	0 diff (100 %id)
CT000915	T-Lymphocytes	XPOT.a	138 to 703	1 to 566				566/570 (99 %)	1 diff (99.9 %id)
CF593436	Human Placenta, placenta	XPOT.a	140 to 881	29 to 780				752/860 (87 %)	25 diff (97.1 %id)
CT002674	T-Lymphocytes	XPOT.a	143 to 981	1 to 841				841/842 (99 %)	4 diff (99.6 %id)
BY795926	eye	XPOT.a	145 to 774	1 to 626				626/626 (100 %)	2 diff (99.7 %id)
BU170214	large cell carcinoma, lung	XPOT.a	149 to 798	1 to 653				653/910 (71 %)	15 diff (98.4 %id)
BU521918	leiomyosarcoma, uterus	XPOT.a	149 to 980	1 to 842				842/871 (96 %)	19 diff (97.9 %id)
DA756353		XPOT.a	201 to 751	2 to 553		capped		552/552 (100 %)	2 diff (99.7 %id)
DA450714	tongue, tumor tissue	XPOT.a	203 to 775	2 to 576		capped		575/575 (100 %)	2 diff (99.7 %id)
DA457773	tongue, tumor tissue	XPOT.a	203 to 776	2 to 576		capped		575/575 (100 %)	1 diff (99.9 %id)
DB139806	thymus	XPOT.a	203 to 731	2 to 532		capped		531/533 (99 %)	6 diff (98.9 %id)
DA460294	tongue, tumor tissue	XPOT.a	205 to 772	2 to 570		capped		569/569 (100 %)	1 diff (99.9 %id)
BX472661		XPOT.a	206 to 786	10 to 590				581/590 (98 %)	7 diff (98.9 %id)
DA460814	tongue, tumor tissue	XPOT.a	207 to 779	2 to 575		capped		574/574 (100 %)	1 diff (99.9 %id)
DA886122		XPOT.a	207 to 761	2 to 557		capped		556/556 (100 %)	2 diff (99.7 %id)
AK292884	trachea	XPOT.a	210 to 3732	1 to 3523	I662T M803V			3523/3523 (100 %)	2 diff (100.0 %id)
DB223504	trachea	XPOT.a	211 to 776	2 to 567		capped		566/566 (100 %)	0 diff (100 %id)
BP873192	embryonal kidney	XPOT.a	212 to 544	1 to 333				333/333 (100 %)	1 diff (99.7 %id)
DA235886	brain	XPOT.a	213 to 795	2 to 584		capped		583/583 (100 %)	1 diff (99.9 %id)
CD656864	Embryonic Stem cells	XPOT.a	226 to 960	12 to 744				733/844 (86 %)	11 diff (98.7 %id)
CF995843	mixed	XPOT.a	238 to 970	1 to 727				727/754 (96 %)	12 diff (98.5 %id)
BX472773		XPOT.a	241 to 773	1 to 533			Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	533/533 (100 %)	1 diff (99.9 %id)
BG388383	embryonal carcinoma, cell line, testis	XPOT.a	245 to 992	1 to 749				749/1103 (67 %)	18 diff (98.4 %id)
CX755952	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	XPOT.a	259 to 925	1 to 668			Submitted on the opposite strand	668/702 (95 %)	6 diff (99.2 %id)
CN409162	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	303 to 993	1 to 692				692/692 (100 %)	3 diff (99.6 %id)
CN409157	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	374 to 777	1 to 404				404/447 (90 %)	4 diff (99.2 %id)
CR976894	T-Lymphocytes	XPOT.a	421 to 766	1 to 346				346/347 (99 %)	2 diff (99.5 %id)
BM466465	eye, retinoblastoma	XPOT.a	433 to 974	41 to 588				548/1129 (48 %)	28 diff (97.6 %id)
BC020569	Lymph, lymphoma	XPOT.a	444 to 3967	1 to 3524		available from MGC, AAA		3524/3524 (100 %)	6 diff (99.9 %id)
BG177873	lymph, lymphoma, cell line	XPOT.a	448 to 1134	6 to 688				683/964 (70 %)	15 diff (98.5 %id)
DA800394	brain	XPOT.a	467 to 1045	2 to 580		capped		579/579 (100 %)	1 diff (99.9 %id)
AA307141	colon	XPOT.a	469 to 869	1 to 400				400/400 (100 %)	5 diff (98.8 %id)
Y16414		XPOT.a	471 to 3967	1 to 3497		tiling clone,		3497/3497 (100 %)	0 diff (100 %id)
DN990721	brain, whole brain	XPOT.a	477 to 1122	5 to 652				648/652 (99 %)	8 diff (98.8 %id)
DB214271	trachea	XPOT.a	497 to 1067	2 to 572		capped		571/571 (100 %)	0 diff (100 %id)
CF136803	lymph	XPOT.a	504 to 873	8 to 377				370/377 (98 %)	8 diff (97.9 %id)
TI_154165999		XPOT.a	504 to 1002	80 to 577				498/498 (100 %)	8 diff (98.4 %id)
BX474660		XPOT.a	523 to 1116	1 to 594				594/594 (100 %)	0 diff (100 %id)
AF039022		XPOT.a	529 to 3417	1 to 2889				2889/2889 (100 %)	2 diff (100.0 %id)
BG955087	colon	XPOT.a	532 to 905	375 to 3				373/375 (99 %)	0 diff (100 %id)
BQ072593	leukocyte	XPOT.a	537 to 1186	1 to 653				653/1125 (58 %)	15 diff (98.7 %id)
AU132672		XPOT.a	579 to 1381	2 to 804		capped		803/836 (96 %)	12 diff (98.6 %id)
CN409164	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	681 to 1291	1 to 611				611/611 (100 %)	0 diff (100 %id)
DA227515	brain	XPOT.a	707 to 1360	2 to 655		capped		654/654 (100 %)	0 diff (100 %id)
AW993675	breast_normal	XPOT.a	711 to 911	386 to 186			Submitted on the opposite strand	201/386 (52 %)	0 diff (100 %id)
AA113097		XPOT.a	749 to 1152	1 to 404				404/404 (100 %)	3 diff (99.3 %id)
DB276038	uterus	XPOT.a	791 to 1329	2 to 541		capped		540/540 (100 %)	6 diff (98.9 %id)
AW996867	breast_normal	XPOT.a	810 to 1246	436 to 1			Submitted on the opposite strand	436/436 (100 %)	3 diff (99.4 %id)
EH332045		XPOT.a	820 to 897	1 to 77				77/79 (97 %)	3 diff (96.3 %id)
BU430890	lymph	XPOT.a	832 to 1281	8 to 457				450/457 (98 %)	5 diff (99.0 %id)
TI_154152629		XPOT.a	832 to 1339	80 to 587				508/510 (99 %)	9 diff (98.3 %id)
CD642924	Embryonic Stem cells	XPOT.a	845 to 1579	10 to 744				735/753 (97 %)	12 diff (98.5 %id)
DB132027	thymus	XPOT.a	867 to 1430	2 to 565		capped		564/564 (100 %)	0 diff (100 %id)
BE017998	cervical carcinoma cell line, cervix	XPOT.a	894 to 1398	12 to 516				505/516 (97 %)	7 diff (98.7 %id)
DB089146	testis	XPOT.a	904 to 1449	2 to 547		capped		546/546 (100 %)	0 diff (100 %id)
BG826945	muscle, rhabdomyosarcoma	XPOT.a	947 to 1497	1 to 551				551/551 (100 %)	1 diff (99.9 %id)
BQ214174	embryonal carcinoma, cell line, testis	XPOT.a	964 to 1836	1 to 873				873/875 (99 %)	9 diff (99.0 %id)
CN409151	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	982 to 1612	1 to 631				631/631 (100 %)	6 diff (99.1 %id)
CN409168	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	987 to 1441	1 to 455				455/455 (100 %)	3 diff (99.4 %id)
BI870623	adenocarcinoma, cell line, Liver	XPOT.a	1085 to 1839	1 to 763				763/768 (99 %)	19 diff (97.6 %id)
TI_57230084		XPOT.a	1085 to 1839	89 to 851				763/768 (99 %)	19 diff (97.6 %id)
AU132914		XPOT.a	1108 to 1905	2 to 804		capped		803/804 (99 %)	13 diff (98.4 %id)
AU120844	whole embryo, mainly body	XPOT.a	1111 to 1968	2 to 851		capped		850/859 (98 %)	10 diff (98.9 %id)
AW753206	colon	XPOT.a	1115 to 1209	105 to 11				95/105 (90 %)	0 diff (100 %id)
EC483634	Prostate	XPOT.a	1140 to 1229	90 to 1				90/95 (94 %)	0 diff (100 %id)
EC500393	Prostate	XPOT.a	1229 to 1339	109 to 1				109/109 (100 %)	2 diff (98.2 %id)
BU154261	eye, retinoblastoma	XPOT.a	1230 to 2146	1 to 918				918/918 (100 %)	5 diff (99.5 %id)
EC521736	Prostate	XPOT.a	1263 to 1370	115 to 9				107/115 (93 %)	0 diff (100 %id)
EC536444	Prostate	XPOT.a	1263 to 1372	112 to 4				109/112 (97 %)	0 diff (100 %id)
BE732943	choriocarcinoma, placenta	XPOT.a	1266 to 2024	1 to 755				758/983 (77 %)	29 diff (97.1 %id)
AL041511	testis	XPOT.a	1298 to 1857	1 to 560				560/560 (100 %)	0 diff (100 %id)
AW500282	lymph	XPOT.a	1389 to 1916	8 to 535				528/535 (98 %)	8 diff (98.6 %id)
AU280291		XPOT.a	1397 to 1935	1 to 539				539/539 (100 %)	0 diff (100 %id)
EC585054	Prostate	XPOT.a	1400 to 1511	110 to 1				110/110 (100 %)	4 diff (96.4 %id)
DA458966	tongue, tumor tissue	XPOT.a	1413 to 1937	2 to 528		capped		527/527 (100 %)	3 diff (99.5 %id)
BF797385	lymph, lymphoma, cell line	XPOT.a	1417 to 2069	52 to 707				656/917 (71 %)	15 diff (98.4 %id)
DB198180	trachea	XPOT.a	1446 to 2028	2 to 585		capped		584/584 (100 %)	1 diff (99.9 %id)
AW851507	colon	XPOT.a	1450 to 1953	504 to 1				504/504 (100 %)	0 diff (100 %id)
DA830366	placenta	XPOT.a	1454 to 1889	2 to 437		capped		436/436 (100 %)	2 diff (99.6 %id)
DA989707	synovial membrane tissue from rheumatioidarthritis	XPOT.a	1462 to 1993	2 to 533		capped		532/532 (100 %)	0 diff (100 %id)
EC576317	Prostate	XPOT.a	1470 to 1558	92 to 1				92/93 (98 %)	3 diff (96.8 %id)
BQ051179	large cell carcinoma, lung	XPOT.a	1520 to 2464	51 to 1011				961/1069 (89 %)	36 diff (96.7 %id)
BU173868	epithelioid carcinoma, Pancreas	XPOT.a	1555 to 2424	1 to 873				873/873 (100 %)	13 diff (98.6 %id)
AL039346	testis	XPOT.a	1556 to 1955	1 to 404				404/421 (95 %)	7 diff (98.4 %id)
DA297042	hippocampus	XPOT.a	1560 to 2134	2 to 577		capped		576/576 (100 %)	2 diff (99.7 %id)
EC539488	Prostate	XPOT.a	1587 to 1686	105 to 1				100/105 (95 %)	4 diff (96.2 %id)
BI223094	cervical carcinoma cell line, cervix	XPOT.a	1587 to 2319	1 to 727				727/727 (100 %)	14 diff (98.1 %id)
BI222980	cervical carcinoma cell line, cervix	XPOT.a	1624 to 2322	1 to 699				699/699 (100 %)	4 diff (99.5 %id)
CX166075	human embryonic stem cells differentiated toan early endodermal cell type	XPOT.a	1631 to 2504	1 to 874				874/874 (100 %)	2 diff (99.8 %id)
BG482185	choriocarcinoma, placenta	XPOT.a	1650 to 2383	1 to 736				736/736 (100 %)	4 diff (99.5 %id)
BU162234	leiomyosarcoma, uterus	XPOT.a	1656 to 2418	12 to 777				766/790 (96 %)	10 diff (98.8 %id)
BE732122	choriocarcinoma, placenta	XPOT.a	1671 to 2366	1 to 695				695/697 (99 %)	7 diff (99.0 %id)
DA545874		XPOT.a	1681 to 2250	2 to 572		capped		571/571 (100 %)	5 diff (99.2 %id)
AW505149	lymph	XPOT.a	1682 to 1992	2 to 312				311/312 (99 %)	6 diff (98.1 %id)
CN409155	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.a	1715 to 2410	1 to 697				697/697 (100 %)	3 diff (99.6 %id)
AA211459		XPOT.a	1733 to 2256	1 to 525			Submitted on the opposite strand	525/525 (100 %)	6 diff (98.9 %id)
BM474586	eye, retinoblastoma	XPOT.a	1750 to 2505	1 to 758				758/1093 (69 %)	21 diff (98.1 %id)
CN409159	embryonic stem cells, DMSO-treated H9 cellline	XPOT.a	1761 to 2436	1 to 677				677/677 (100 %)	1 diff (99.9 %id)
BE560571	Burkitt lymphoma, lymph	XPOT.a	1789 to 2508	1 to 712				712/785 (90 %)	16 diff (98.0 %id)
DB180113	kidney, tumor tissue	XPOT.a	1822 to 2367	2 to 547		capped		546/546 (100 %)	0 diff (100 %id)
AA361631		XPOT.a	1853 to 2167	1 to 315				315/315 (100 %)	0 diff (100 %id)
BU164503	large cell carcinoma, lung	XPOT.a	1876 to 2749	1 to 883				883/884 (99 %)	18 diff (98.0 %id)
BE079848	breast	XPOT.a	1881 to 2203	1 to 323				323/323 (100 %)	0 diff (100 %id)
DA343466	substantia nigra	XPOT.a	1881 to 2449	2 to 570		capped		569/569 (100 %)	0 diff (100 %id)
CN409152	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	1882 to 2247	1 to 367				367/367 (100 %)	4 diff (99.0 %id)
BI087860	cervix	XPOT.a	1927 to 2723	1 to 795				795/798 (99 %)	10 diff (98.8 %id)
DB187221	liver, tumor tissue	XPOT.a	1943 to 2498	2 to 557		capped		556/556 (100 %)	0 diff (100 %id)
CN409156	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	1957 to 2678	1 to 722				722/722 (100 %)	0 diff (100 %id)
BE544824	cervical carcinoma cell line, cervix	XPOT.a	1960 to 2752	1 to 774				774/953 (81 %)	26 diff (97.3 %id)
AW419198	endometrioid ovarian metastasis, ovary	XPOT.a	1981 to 2430	492 to 43				450/519 (86 %)	3 diff (99.5 %id)
BQ438030	leiomyosarcoma, uterus	XPOT.a	1992 to 2811	1 to 823				823/823 (100 %)	5 diff (99.4 %id)
BG388870	embryonal carcinoma, cell line, testis	XPOT.a	2036 to 2829	1 to 785				785/787 (99 %)	17 diff (97.9 %id)
CN409160	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.a	2053 to 2706	22 to 675				654/675 (96 %)	6 diff (99.2 %id)
BG570786	placenta	XPOT.a	2075 to 2828	1 to 754				754/754 (100 %)	2 diff (99.8 %id)
BF665593	brain, primitive neuroectoderm	XPOT.a	2085 to 2689	1 to 603				603/603 (100 %)	2 diff (99.7 %id)
BF669422	brain, primitive neuroectoderm	XPOT.a	2085 to 2794	1 to 697				697/886 (78 %)	30 diff (96.7 %id)
AU124177		XPOT.a	2089 to 2767	2 to 674		capped		673/675 (99 %)	7 diff (99.0 %id)
BF896325	marrow	XPOT.a	2090 to 2343	298 to 45			Submitted on the opposite strand	254/298 (85 %)	0 diff (100 %id)
BF896327	marrow	XPOT.a	2090 to 2343	299 to 46			Submitted on the opposite strand	254/299 (84 %)	0 diff (100 %id)
BF896336	marrow	XPOT.a	2090 to 2343	265 to 12			Submitted on the opposite strand	254/265 (95 %)	7 diff (97.4 %id)
AA353362		XPOT.a	2117 to 2394	1 to 278				278/278 (100 %)	1 diff (99.7 %id)
R19997	whole brain	XPOT.a	2143 to 2547	1 to 411				409/411 (99 %)	8 diff (98.1 %id)
BM454918	leiomyosarcoma, uterus	XPOT.a	2157 to 3097	1 to 951				951/1140 (83 %)	30 diff (97.4 %id)
CR613510	Neuroblastoma Cot 25-normalized	XPOT.a	2168 to 3937	1 to 1770				1770/1770 (100 %)	0 diff (100 %id)
AL527459	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	XPOT.a	2168 to 3044	1 to 878		fully sequenced,		878/878 (100 %)	1 diff (99.9 %id)
BE909043	epithelioid carcinoma, Pancreas	XPOT.a	2170 to 2760	1 to 592				592/592 (100 %)	1 diff (99.9 %id)
BQ894570	dorsal root ganglia	XPOT.a	2193 to 3107	1 to 915				915/916 (99 %)	7 diff (99.3 %id)
BG166199	hypernephroma, cell line, Kidney	XPOT.a	2201 to 2921	1 to 720				720/777 (92 %)	22 diff (97.2 %id)
BM928267	brain	XPOT.a	2205 to 2983	1 to 780				780/1066 (73 %)	21 diff (98.1 %id)
BM014878	breast, mammary adenocarcinoma, cell line	XPOT.a	2210 to 3096	1 to 882				882/882 (100 %)	15 diff (98.3 %id)
TI_59392957		XPOT.a	2210 to 3096	90 to 971				882/882 (100 %)	15 diff (98.3 %id)
BM751416	Ascites, stomach	XPOT.a	2211 to 2575	1 to 365				365/365 (100 %)	2 diff (99.5 %id)
CN409158	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	2231 to 2648	1 to 418				418/418 (100 %)	2 diff (99.6 %id)
DA831270	placenta	XPOT.a	2231 to 2981	2 to 752		capped		751/755 (99 %)	7 diff (99.1 %id)
DA802543	brain	XPOT.a	2247 to 2797	2 to 552		capped		551/551 (100 %)	0 diff (100 %id)
BE535571	cervix	XPOT.a	2274 to 2988	1 to 716				716/878 (81 %)	30 diff (96.6 %id)
BU072595	Pancreas, Purified pancreatic islet	XPOT.a	2285 to 2925	1 to 642				642/642 (100 %)	13 diff (98.0 %id)
FN150848	breast carcinoma	XPOT.a	2302 to 2405	98 to 1			Submitted on the opposite strand	98/98 (100 %)	9 diff (90.9 %id)
BQ220663	melanotic melanoma, skin	XPOT.a	2303 to 3177	1 to 877				877/879 (99 %)	5 diff (99.5 %id)
BC000950	Placenta, choriocarcinoma	XPOT.a	2305 to 3967	1 to 1663		available from MGC, AAA		1663/1663 (100 %)	2 diff (99.9 %id)
BG257188	embryonal carcinoma, cell line, testis	XPOT.a	2319 to 3047	1 to 730				730/990 (73 %)	15 diff (98.5 %id)
BE539935	cervix	XPOT.a	2323 to 2993	1 to 668		available from MGC,		668/903 (73 %)	24 diff (97.4 %id)
BM452917	melanotic melanoma, skin	XPOT.a	2329 to 3153	8 to 838				831/917 (90 %)	16 diff (98.3 %id)
BU171913	melanotic melanoma, skin	XPOT.a	2334 to 3165	11 to 848				838/849 (98 %)	12 diff (98.6 %id)
BI871363	adenocarcinoma, cell line, Liver	XPOT.a	2338 to 3152	1 to 815				815/817 (99 %)	7 diff (99.2 %id)
TI_57228425		XPOT.a	2338 to 3152	51 to 865				815/817 (99 %)	7 diff (99.2 %id)
BE886490	leiomyosarcoma, uterus	XPOT.a	2341 to 2955	1 to 615				615/922 (66 %)	1 diff (99.9 %id)
BF943804	nervous_normal	XPOT.a	2351 to 2687	17 to 353				337/353 (95 %)	14 diff (96.1 %id)
DR761093	embryonic stem	XPOT.a	2370 to 3137	1 to 768				768/768 (100 %)	0 diff (100 %id)
BI857962	breast, mammary adenocarcinoma, cell line	XPOT.a	2411 to 2911	1 to 501				501/501 (100 %)	0 diff (100 %id)
TI_57191155		XPOT.a	2411 to 2911	56 to 556				501/501 (100 %)	0 diff (100 %id)
ES308778	beard hair, skin	XPOT.a	2426 to 2587	1 to 162				162/162 (100 %)	0 diff (100 %id)
AA471375		XPOT.a	2432 to 2672	1 to 239				239/239 (100 %)	3 diff (98.8 %id)
BG250370	adenocarcinoma, cell line, Liver	XPOT.a	2436 to 3112	1 to 677				677/677 (100 %)	5 diff (99.3 %id)
CN409154	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	2449 to 3213	9 to 774				766/774 (98 %)	6 diff (99.3 %id)
BF094363	uterus_tumor	XPOT.a	2450 to 2779	340 to 11				330/340 (97 %)	0 diff (100 %id)
AA345352	gall bladder	XPOT.a	2478 to 2749	1 to 272				272/272 (100 %)	0 diff (100 %id)
BE535752	cervix	XPOT.a	2480 to 3215	1 to 736				736/737 (99 %)	29 diff (96.1 %id)
BF379910	uterus_tumor	XPOT.a	2487 to 2775	289 to 1				289/289 (100 %)	3 diff (99.0 %id)
BG743612	skin	XPOT.a	2494 to 3392	1 to 907				907/975 (93 %)	20 diff (98.0 %id)
BG120465	adenocarcinoma, cell line, Liver	XPOT.a	2496 to 3091	1 to 598				598/598 (100 %)	3 diff (99.5 %id)
BG167504	hypernephroma, cell line, Kidney	XPOT.a	2503 to 3097	52 to 644				593/1005 (59 %)	14 diff (98.7 %id)
CD514733	White Matter	XPOT.a	2509 to 3308	1 to 803				803/871 (92 %)	7 diff (99.2 %id)
BM053031	Islets of Langerhans, Pancreas	XPOT.a	2521 to 3117	1 to 597				597/597 (100 %)	0 diff (100 %id)
CN409153	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.a	2533 to 3221	1 to 688				688/688 (100 %)	1 diff (99.9 %id)
BE018475	cervix	XPOT.a	2544 to 2865	1 to 322				322/322 (100 %)	1 diff (99.7 %id)
BF219458	brain, glioblastoma	XPOT.a	2557 to 3098	1 to 543				543/896 (60 %)	10 diff (98.9 %id)
BM806204	leiomyosarcoma, uterus	XPOT.a	2565 to 3396	1 to 838				838/1160 (72 %)	20 diff (98.3 %id)
BE540009	cervix	XPOT.a	2569 to 3262	1 to 700				700/756 (92 %)	25 diff (96.7 %id)
R17472. matches multiple genes	whole brain	XPOT.a	2572 to 3066	1 to 505			also hits gene sekomu	505/509 (99 %)	15 diff (97.1 %id)
BE827148	lung_tumor	XPOT.a	2578 to 2921	343 to 1				343/343 (100 %)	2 diff (99.5 %id)
BF341426	brain, glioblastoma with EGFR amplification	XPOT.a	2582 to 3302	1 to 714				716/901 (79 %)	20 diff (97.8 %id)
BG251359	adenocarcinoma, cell line, Liver	XPOT.a	2582 to 3332	1 to 796				575/857 (67 %)	38 diff (95.6 %id)
BQ433963	melanotic melanoma, skin	XPOT.a	2586 to 3071	1 to 486				486/991 (49 %)	6 diff (99.4 %id)
BE538464	cervix	XPOT.a	2605 to 3290	1 to 681				683/685 (99 %)	11 diff (98.4 %id)
CX785771	human embryonic stem cells	XPOT.a	2610 to 3466	1 to 857				857/857 (100 %)	0 diff (100 %id)
BU509725	leiomyosarcoma, uterus	XPOT.a	2611 to 3391	1 to 791				791/892 (88 %)	10 diff (98.9 %id)
BI087410	cervix	XPOT.a	2628 to 3224	1 to 597				597/600 (99 %)	2 diff (99.7 %id)
AA094023		XPOT.a	2630 to 2919	1 to 281				281/283 (99 %)	12 diff (95.8 %id)
AA094220		XPOT.a	2630 to 2908	1 to 274				274/274 (100 %)	6 diff (97.9 %id)
N55692		XPOT.a	2631 to 2910	1 to 280				280/280 (100 %)	8 diff (97.2 %id)
BG537290	lung	XPOT.a	2642 to 3260	1 to 627				623/751 (82 %)	32 diff (95.8 %id)
R68485	placenta	XPOT.a	2645 to 3030	1 to 404				404/404 (100 %)	27 diff (93.4 %id)
R80080	placenta	XPOT.a	2645 to 2983	1 to 342				342/475 (72 %)	4 diff (99.2 %id)
CF143454	lymph	XPOT.a	2656 to 2983	8 to 335				328/335 (97 %)	7 diff (98.0 %id)
AA010473	liver and spleen	XPOT.a	2658 to 3120	1 to 464				464/464 (100 %)	3 diff (99.4 %id)
T83401	liver and spleen	XPOT.a	2659 to 3031	1 to 380				380/408 (93 %)	12 diff (97.1 %id)
BM014810	breast, mammary adenocarcinoma, cell line	XPOT.a	2661 to 3323	1 to 662				662/662 (100 %)	1 diff (99.9 %id)
TI_59392873		XPOT.a	2661 to 3323	84 to 745				662/662 (100 %)	1 diff (99.9 %id)
AW960422		XPOT.a	2670 to 3262	1 to 591				591/630 (93 %)	12 diff (98.1 %id)
AA167618		XPOT.a	2670 to 3211	1 to 528			Submitted on the opposite strand	528/560 (94 %)	19 diff (96.7 %id)
AA305457	colon	XPOT.a	2673 to 3040	1 to 366				366/366 (100 %)	2 diff (99.5 %id)
CN484720	eye	XPOT.a	2676 to 3214	109 to 647				539/657 (82 %)	12 diff (98.2 %id)
BG533655	Liver	XPOT.a	2691 to 3392	1 to 706				706/822 (85 %)	15 diff (98.2 %id)
BG687489	lung, mucoepidermoid carcinoma	XPOT.a	2694 to 3528	1 to 839				813/868 (93 %)	52 diff (94.1 %id)
BF132816	lung, mucoepidermoid carcinoma	XPOT.a	2714 to 3324	1 to 603				603/893 (67 %)	9 diff (99.0 %id)
BF670079	brain, primitive neuroectoderm	XPOT.a	2715 to 3334	1 to 608				610/857 (71 %)	15 diff (98.3 %id)
BF212719	bone marrow, from chronic myelogenous leukemia	XPOT.a	2723 to 3284	1 to 565				565/565 (100 %)	17 diff (97.0 %id)
BG998503	head_neck	XPOT.a	2727 to 2973	272 to 29				244/276 (88 %)	14 diff (95.0 %id)
EL947237	eyeball	XPOT.a	2730 to 3190	1 to 460				460/460 (100 %)	7 diff (98.5 %id)
N55853		XPOT.a	2738 to 2931	1 to 190				190/191 (99 %)	5 diff (97.4 %id)
BF927827	nervous_tumor	XPOT.a	2747 to 3113	13 to 379				367/379 (96 %)	4 diff (99.0 %id)
DR760194	embryonic stem	XPOT.a	2759 to 3540	14 to 794				781/794 (98 %)	11 diff (98.7 %id)
BF669315	brain, primitive neuroectoderm	XPOT.a	2778 to 3334	1 to 551				551/837 (65 %)	13 diff (98.5 %id)
CR736614	uterus	XPOT.a	2782 to 3624	1 to 843				843/844 (99 %)	5 diff (99.5 %id)
BF742617	breast	XPOT.a	2784 to 3075	125 to 416				292/416 (70 %)	8 diff (98.1 %id)
CN409167	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	2787 to 3485	1 to 700				700/700 (100 %)	1 diff (99.9 %id)
BF793383	adrenal cortex carcinoma, cell line, adrenal gland	XPOT.a	2789 to 3623	8 to 845				838/845 (99 %)	29 diff (96.6 %id)
AA255978	germinal center B cell	XPOT.a	2844 to 3332	1 to 490				490/490 (100 %)	2 diff (99.6 %id)
AW968098		XPOT.a	2845 to 3496	1 to 656				656/657 (99 %)	9 diff (98.7 %id)
CB144064	Liver	XPOT.a	2848 to 3316	1 to 469				469/469 (100 %)	0 diff (100 %id)
EH328059		XPOT.a	2857 to 2926	1 to 69				69/69 (100 %)	1 diff (98.6 %id)
CB962912	Blood vessels - aorta, basilar and artery	XPOT.a	2860 to 3599	1 to 746				746/747 (99 %)	15 diff (98.0 %id)
AA062665	cornea	XPOT.a	2866 to 3283	1 to 418				418/418 (100 %)	2 diff (99.6 %id)
AL135540	melanoma (MeWo cell line)	XPOT.a	2910 to 3271	1 to 363				363/363 (100 %)	1 diff (99.8 %id)
Z25345	leg muscle, skeletal muscle	XPOT.a	2911 to 3193	1 to 283				283/287 (98 %)	4 diff (98.7 %id)
CB998655	Blood vessels - aorta, basilar and artery	XPOT.a	2914 to 3672	1 to 775				775/791 (97 %)	25 diff (96.9 %id)
BI256440	cervical carcinoma cell line, cervix	XPOT.a	2957 to 3904	9 to 957				949/957 (99 %)	30 diff (96.9 %id)
BE621367	epithelioid carcinoma, Pancreas	XPOT.a	2958 to 3644	1 to 681				681/681 (100 %)	16 diff (97.7 %id)
W75942	heart	XPOT.a	2960 to 3410	1 to 455				455/455 (100 %)	5 diff (99.0 %id)
BG107100	lymph, lymphoma, cell line	XPOT.a	2960 to 3759	1 to 802				802/1026 (78 %)	24 diff (97.7 %id)
AW992263	breast_normal	XPOT.a	2963 to 3192	6 to 234				229/234 (97 %)	6 diff (97.5 %id)
BF907949	uterus_tumor	XPOT.a	2979 to 3140	25 to 186				162/186 (87 %)	6 diff (96.8 %id)
BF808204	colon_ins	XPOT.a	2983 to 3193	1 to 211				211/212 (99 %)	1 diff (99.6 %id)
AV681828	hepatocellular carcinoma	XPOT.a	3006 to 3775	1 to 766				766/773 (99 %)	32 diff (95.9 %id)
CF128915	Chondrosarcoma Lung Metastasis cell lines, lung	XPOT.a	3013 to 3731	1 to 719				719/719 (100 %)	3 diff (99.6 %id)
TI_154189071		XPOT.a	3013 to 3875	51 to 904				854/1001 (85 %)	22 diff (97.9 %id)
AL527420	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	XPOT.a	3014 to 3933	922 to 4		fully sequenced,		919/922 (99 %)	2 diff (99.8 %id)
AV759529	bone marrow	XPOT.a	3024 to 3793	1 to 766				766/788 (97 %)	12 diff (98.5 %id)
AI743638	pooled	XPOT.a	3062 to 3545	1 to 484			Submitted on the opposite strand	484/484 (100 %)	5 diff (99.0 %id)
N44501	melanocyte	XPOT.a	3075 to 3380	1 to 309				309/310 (99 %)	6 diff (98.1 %id)
TI_154125246		XPOT.a	3098 to 3967	953 to 81		AAA		873/1018 (85 %)	12 diff (98.9 %id)
BF207658	bladder, carcinoma, cell line	XPOT.a	3101 to 3784	1 to 675				671/876 (76 %)	29 diff (96.7 %id)
BG260699	bladder, transitional cell papilloma, cell line	XPOT.a	3106 to 3880	1 to 766				766/970 (78 %)	21 diff (97.9 %id)
BM856192	stomach	XPOT.a	3120 to 3386	1 to 266				266/266 (100 %)	1 diff (99.7 %id)
BQ082805	stomach	XPOT.a	3120 to 3637	1 to 518				518/518 (100 %)	3 diff (99.5 %id)
BM825699	stomach	XPOT.a	3120 to 3322	1 to 202				202/202 (100 %)	1 diff (99.6 %id)
BG257996	embryonal carcinoma, cell line, testis	XPOT.a	3127 to 3917	1 to 782				782/969 (80 %)	18 diff (98.2 %id)
CN409166	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	3131 to 3700	1 to 570				570/570 (100 %)	0 diff (100 %id)
BU159696	eye, retinoblastoma	XPOT.a	3133 to 3975	894 to 36		AAA	Submitted on the opposite strand	855/859 (99 %)	15 diff (98.3 %id)
TI_154125945		XPOT.a	3150 to 3966	901 to 87		AAA		811/944 (85 %)	30 diff (96.9 %id)
BI087202	cervix	XPOT.a	3164 to 3749	1 to 594				594/767 (77 %)	17 diff (97.8 %id)
TI_159723814		XPOT.a	3179 to 3967	859 to 68		AAA		788/1000 (78 %)	17 diff (98.3 %id)
N28562	melanocyte	XPOT.a	3192 to 3579	1 to 393		fully sequenced,		393/393 (100 %)	0 diff (100 %id)
BU622587	cell lines, Chondrosarcoma	XPOT.a	3193 to 3966	791 to 19		AAA		774/773 (100 %)	10 diff (98.8 %id)
N27568	melanocyte	XPOT.a	3194 to 3593	1 to 405		fully sequenced,		405/405 (100 %)	0 diff (100 %id)
DR156701	human embryonic stem cells differentiated toan early endodermal cell type	XPOT.a	3215 to 4064	1 to 850				850/850 (100 %)	0 diff (100 %id)
TI_154126453		XPOT.a	3217 to 3966	813 to 73		AAA		741/953 (77 %)	16 diff (98.4 %id)
CA416149	Chondrosarcoma Cell line	XPOT.a	3220 to 3967	768 to 19		AAA		750/750 (100 %)	4 diff (99.5 %id)
BQ014066	Chondrosarcoma, Left Pubic Bone	XPOT.a	3223 to 3966	764 to 19		AAA		746/746 (100 %)	7 diff (99.1 %id)
BQ775277	Bone, Human Chondrosarcoma Cell Line	XPOT.a	3223 to 3966	760 to 19		AAA		742/742 (100 %)	7 diff (99.1 %id)
BM683701. matches multiple genes	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	XPOT.a	3224 to 3966	762 to 19		AAA	also hits gene sekomu	744/744 (100 %)	4 diff (99.5 %id)
BE815403	breast_normal	XPOT.a	3235 to 3571	345 to 9				337/345 (97 %)	0 diff (100 %id)
CR745064		XPOT.a	3241 to 3974	735 to 2			Submitted on the opposite strand	734/735 (99 %)	1 diff (99.9 %id)
AA598447	lung, lung carcinoma	XPOT.a	3242 to 3625	384 to 1				384/384 (100 %)	0 diff (100 %id)
BE621621	epithelioid carcinoma, Pancreas	XPOT.a	3247 to 3914	677 to 2				676/678 (99 %)	2 diff (99.8 %id)
CR742958	ovarian tumor, ovary	XPOT.a	3248 to 3974	728 to 2			Submitted on the opposite strand	727/728 (99 %)	0 diff (100 %id)
BQ009137	Chondrosarcoma, Left Pubic Bone	XPOT.a	3255 to 3967	732 to 19		AAA		714/714 (100 %)	1 diff (99.9 %id)
TI_154100352		XPOT.a	3255 to 3966	767 to 64		AAA		704/705 (99 %)	19 diff (97.4 %id)
BG188817		XPOT.a	3256 to 3868	1 to 614				614/1019 (60 %)	35 diff (96.6 %id)
CR617666	fetal liver	XPOT.a	3261 to 3974	1 to 714				714/714 (100 %)	0 diff (100 %id)
BX345186		XPOT.a	3261 to 3971	1 to 714				714/718 (99 %)	9 diff (98.8 %id)
BX448498	fetal liver, Liver	XPOT.a	3261 to 3974	1 to 713		fully sequenced,		713/713 (100 %)	1 diff (99.9 %id)
AI984005	adenocarcinoma, Pancreas	XPOT.a	3261 to 3967	704 to 1				704/721 (97 %)	8 diff (98.9 %id)
BQ004501	Chondrosarcoma, Left Pelvis	XPOT.a	3261 to 3972	731 to 19		AAA		713/718 (99 %)	4 diff (99.5 %id)
BM452001	eye, retinoblastoma	XPOT.a	3274 to 3967	8 to 701		AAA		694/701 (99 %)	6 diff (99.2 %id)
CA416583	Chondrosarcoma Cell line	XPOT.a	3274 to 3966	708 to 19		AAA		690/690 (100 %)	11 diff (98.5 %id)
BG214290		XPOT.a	3283 to 3970	1 to 684				684/734 (93 %)	23 diff (96.9 %id)
BQ019773	Chondrosarcoma, Left Pubic Bone	XPOT.a	3285 to 3966	703 to 19		AAA		685/685 (100 %)	7 diff (99.0 %id)
CA425872	cell lines, Chondrosarcoma	XPOT.a	3285 to 3967	702 to 19		AAA		684/684 (100 %)	1 diff (99.9 %id)
BE140134	head_neck	XPOT.a	3287 to 3794	1 to 508				508/508 (100 %)	3 diff (99.5 %id)
BE140151	head_neck	XPOT.a	3287 to 3794	1 to 506				506/506 (100 %)	5 diff (99.1 %id)
AW029508	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	XPOT.a	3288 to 3973	685 to 3				685/708 (96 %)	15 diff (97.9 %id)
BU623631	cell lines, Enchondroma	XPOT.a	3288 to 3966	698 to 19		AAA		680/680 (100 %)	4 diff (99.5 %id)
AW614651	Kidney	XPOT.a	3289 to 3972	684 to 1				684/687 (99 %)	5 diff (99.3 %id)
CA416234	Chondrosarcoma Cell line	XPOT.a	3299 to 3966	686 to 19		AAA		668/668 (100 %)	11 diff (98.4 %id)
EH347870		XPOT.a	3301 to 3371	1 to 71				71/71 (100 %)	0 diff (100 %id)
BF812638	colon_ins	XPOT.a	3302 to 3483	181 to 1			Submitted on the opposite strand	181/181 (100 %)	8 diff (95.6 %id)
EH346683		XPOT.a	3302 to 3371	1 to 70				70/70 (100 %)	4 diff (94.3 %id)
EH345481		XPOT.a	3304 to 3370	1 to 67				67/67 (100 %)	1 diff (98.6 %id)
BU632742	cell lines, Chondrosarcoma	XPOT.a	3313 to 3973	677 to 19		AAA		659/659 (100 %)	9 diff (98.7 %id)
BU619311	Cell Line, Chondrosarcoma	XPOT.a	3314 to 3966	672 to 19		AAA		654/654 (100 %)	4 diff (99.4 %id)
BG209556		XPOT.a	3330 to 3976	1 to 651		AAA		651/651 (100 %)	13 diff (98.1 %id)
BG215895		XPOT.a	3330 to 3973	1 to 645		AAA		645/645 (100 %)	9 diff (98.7 %id)
BU072322	Pancreas, Purified pancreatic islet	XPOT.a	3343 to 3967	636 to 11		AAA		626/626 (100 %)	11 diff (98.3 %id)
BX448497	fetal liver, Liver	XPOT.a	3347 to 3942	616 to 20		fully sequenced,		597/616 (96 %)	3 diff (99.6 %id)
DW415160	Liver	XPOT.a	3347 to 3659	1 to 313				313/313 (100 %)	8 diff (97.5 %id)
DB497121	hypothalamus	XPOT.a	3348 to 3826	1 to 480				480/480 (100 %)	4 diff (99.2 %id)
BF812627	colon_ins	XPOT.a	3349 to 3734	392 to 11			Submitted on the opposite strand	382/447 (85 %)	0 diff (100 %id)
BF245130	brain, glioblastoma	XPOT.a	3356 to 3976	1 to 620				620/769 (80 %)	19 diff (97.6 %id)
AW876889	pnet	XPOT.a	3357 to 3911	557 to 1				557/557 (100 %)	7 diff (98.8 %id)
BU631975	cell lines, Chondrosarcoma	XPOT.a	3359 to 3966	628 to 19		AAA		610/610 (100 %)	5 diff (99.2 %id)
BG218378		XPOT.a	3389 to 3967	1 to 579		AAA		579/579 (100 %)	10 diff (98.3 %id)
DB375505	placenta	XPOT.a	3396 to 3973	577 to 1				577/587 (98 %)	25 diff (95.8 %id)
CA441334	Fibrosarcoma	XPOT.a	3396 to 3967	591 to 19		AAA		573/573 (100 %)	1 diff (99.9 %id)
BQ019479	Chondrosarcoma, Left Pubic Bone	XPOT.a	3398 to 3967	589 to 19		AAA		571/571 (100 %)	3 diff (99.5 %id)
CV312076	stomach	XPOT.a	3401 to 3820	427 to 8			Submitted on the opposite strand	420/428 (98 %)	16 diff (96.3 %id)
DB359685	whole embryo, mainly body	XPOT.a	3415 to 3967	552 to 1				552/552 (100 %)	8 diff (98.6 %id)
BI259426	cervical carcinoma cell line, cervix	XPOT.a	3423 to 3974	1 to 547		AAA		547/547 (100 %)	9 diff (98.4 %id)
AA167756		XPOT.a	3427 to 3974	534 to 3			Submitted on the opposite strand	532/541 (98 %)	0 diff (100 %id)
BG165522	hypernephroma, cell line, Kidney	XPOT.a	3431 to 3967	1 to 535		AAA		535/535 (100 %)	2 diff (99.7 %id)
AI472265	pooled	XPOT.a	3438 to 3973	536 to 1				536/536 (100 %)	0 diff (100 %id)
DB369906		XPOT.a	3441 to 3967	527 to 1				527/547 (96 %)	0 diff (100 %id)
DB376856	placenta	XPOT.a	3441 to 3967	523 to 1				523/528 (99 %)	9 diff (98.3 %id)
DB369931		XPOT.a	3444 to 3967	525 to 1				525/525 (100 %)	2 diff (99.7 %id)
BF213226	bone marrow, from acute myelogenous leukemia	XPOT.a	3448 to 4081	1 to 631				631/817 (77 %)	17 diff (98.0 %id)
BX108548	whole brain	XPOT.a	3449 to 3976	540 to 15		AAA		526/526 (100 %)	2 diff (99.7 %id)
BQ227105	embryonal carcinoma, cell line, testis	XPOT.a	3450 to 3967	1 to 519		AAA		519/519 (100 %)	2 diff (99.7 %id)
W72484	heart	XPOT.a	3452 to 3978	534 to 2				533/566 (94 %)	0 diff (100 %id)
BM841010	lymph node, stomach	XPOT.a	3458 to 3956	1 to 498				498/498 (100 %)	1 diff (99.8 %id)
AW081614	colon, moderately differentiated adenocarcinoma	XPOT.a	3459 to 3969	511 to 1				511/511 (100 %)	0 diff (100 %id)
AI568637	anaplastic oligodendroglioma, brain	XPOT.a	3472 to 3973	502 to 1				502/502 (100 %)	0 diff (100 %id)
BG165587	hypernephroma, cell line, Kidney	XPOT.a	3475 to 3969	48 to 546				499/945 (52 %)	32 diff (96.7 %id)
AA922152	pooled	XPOT.a	3476 to 3970	496 to 1				496/496 (100 %)	7 diff (98.6 %id)
AW439503	serous papillary carcinoma, high grade, 2pooled tumors, uterus	XPOT.a	3478 to 3974	497 to 1				497/497 (100 %)	1 diff (99.8 %id)
AW675668. matches multiple genes	cervix	XPOT.a	3478 to 3970	500 to 7			also hits gene XPOTP1	494/500 (98 %)	0 diff (100 %id)
DB369687		XPOT.a	3480 to 3965	489 to 2				488/543 (89 %)	0 diff (100 %id)
BJ992748	hepatoblastoma	XPOT.a	3491 to 3933	443 to 1				443/443 (100 %)	1 diff (99.8 %id)
DB568155	hypothalamus	XPOT.a	3493 to 3976	1 to 483			Submitted on the opposite strand	483/483 (100 %)	3 diff (99.4 %id)
BG026132	Bone, osteosarcoma, cell line	XPOT.a	3495 to 4213	1 to 714				714/950 (75 %)	24 diff (97.5 %id)
DB518642	testis	XPOT.a	3496 to 3974	1 to 479			Submitted on the opposite strand	479/479 (100 %)	0 diff (100 %id)
W69116. matches multiple genes	heart	XPOT.a	3497 to 3967	477 to 1			also hits gene sekomu	477/485 (98 %)	11 diff (97.8 %id)
AI161083	uterus	XPOT.a	3503 to 3967	464 to 1				464/464 (100 %)	2 diff (99.6 %id)
DB527497	testis	XPOT.a	3504 to 3970	1 to 467			Submitted on the opposite strand	467/469 (99 %)	2 diff (99.6 %id)
AI347016	adenocarcinoma, colon	XPOT.a	3504 to 3973	473 to 4				470/473 (99 %)	0 diff (100 %id)
AI862335	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	XPOT.a	3504 to 3977	474 to 1				474/474 (100 %)	0 diff (100 %id)
AI459193	pooled	XPOT.a	3505 to 3976	487 to 17		AAA		471/471 (100 %)	1 diff (99.8 %id)
DB519530	testis	XPOT.a	3508 to 3965	1 to 458			Submitted on the opposite strand	458/460 (99 %)	2 diff (99.6 %id)
AA929057	adenocarcinoma, colon	XPOT.a	3511 to 3973	464 to 2				463/464 (99 %)	0 diff (100 %id)
CN276755	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	3515 to 3901	1 to 387				387/387 (100 %)	0 diff (100 %id)
AI582840	anaplastic oligodendroglioma, brain	XPOT.a	3518 to 3967	450 to 1				450/450 (100 %)	0 diff (100 %id)
DB567268	hypothalamus	XPOT.a	3519 to 3978	1 to 460			Submitted on the opposite strand	460/465 (98 %)	6 diff (98.8 %id)
AA976467	Kidney, kidney tumor	XPOT.a	3520 to 3970	453 to 4				450/453 (99 %)	0 diff (100 %id)
AI702194	carcinoid, lung	XPOT.a	3520 to 3974	457 to 3				455/457 (99 %)	0 diff (100 %id)
AA668988	germinal center B cell	XPOT.a	3523 to 3967	462 to 16		AAA		447/447 (100 %)	3 diff (99.4 %id)
AI077603	senescent fibroblast	XPOT.a	3525 to 3978	456 to 3				454/456 (99 %)	0 diff (100 %id)
BQ002207	Chondrosarcoma, Left Pelvis	XPOT.a	3527 to 3967	460 to 19		AAA		442/442 (100 %)	1 diff (99.8 %id)
BM314606	Pancreas, Purified pancreatic islet	XPOT.a	3528 to 4068	23 to 563				541/563 (96 %)	6 diff (99.0 %id)
AI077599	senescent fibroblast	XPOT.a	3529 to 3978	452 to 3				450/452 (99 %)	0 diff (100 %id)
AA112285		XPOT.a	3531 to 3969	439 to 1				439/439 (100 %)	0 diff (100 %id)
AI150289		XPOT.a	3531 to 3974	447 to 4				444/447 (99 %)	0 diff (100 %id)
AI215517	pooled	XPOT.a	3531 to 3967	437 to 1				437/437 (100 %)	0 diff (100 %id)
AI245787	Kidney	XPOT.a	3531 to 3974	443 to 1				443/443 (100 %)	1 diff (99.8 %id)
AA194650		XPOT.a	3534 to 3972	441 to 2			Submitted on the opposite strand	440/441 (99 %)	0 diff (100 %id)
DB519819	testis	XPOT.a	3535 to 3970	1 to 436			Submitted on the opposite strand	436/438 (99 %)	2 diff (99.6 %id)
R79980	placenta	XPOT.a	3537 to 3969	452 to 5				448/452 (99 %)	0 diff (100 %id)
AI753723	bone marrow stroma	XPOT.a	3542 to 3967	447 to 22		AAA		426/426 (100 %)	0 diff (100 %id)
BM991643	Bone, Subchondral Bone	XPOT.a	3544 to 3976	451 to 19		AAA		433/441 (98 %)	0 diff (100 %id)
BU590018	mixed (pool of 40 RNAs)	XPOT.a	3544 to 3970	1 to 427				427/488 (87 %)	1 diff (99.8 %id)
AA878049	pharynx, squamous cell carcinoma	XPOT.a	3547 to 3965	418 to 1				418/418 (100 %)	4 diff (99.1 %id)
BE887671	leiomyosarcoma, uterus	XPOT.a	3548 to 4331	1 to 792				792/855 (92 %)	45 diff (94.8 %id)
DB507772	testis	XPOT.a	3549 to 3970	1 to 421			Submitted on the opposite strand	421/423 (99 %)	9 diff (97.9 %id)
H99877	melanocyte	XPOT.a	3549 to 3967	423 to 1		fully sequenced,		423/423 (100 %)	4 diff (99.1 %id)
BU189473	melanotic melanoma, skin	XPOT.a	3549 to 3967	1 to 419		AAA		419/419 (100 %)	0 diff (100 %id)
CK821335	Pancreas, Purified pancreatic islet	XPOT.a	3556 to 4145	1 to 590			Submitted on the opposite strand	590/590 (100 %)	0 diff (100 %id)
AA724422	pooled	XPOT.a	3557 to 3968	412 to 1				412/412 (100 %)	1 diff (99.8 %id)
DB561546	hypothalamus	XPOT.a	3558 to 3976	1 to 423			Submitted on the opposite strand	423/423 (100 %)	18 diff (95.8 %id)
AW206505		XPOT.a	3558 to 3972	432 to 18		AAA		415/415 (100 %)	0 diff (100 %id)
CN417818	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	3563 to 3972	8 to 416				409/421 (97 %)	3 diff (99.3 %id)
N20299	melanocyte	XPOT.a	3563 to 3967	408 to 1		fully sequenced,		408/408 (100 %)	4 diff (99.1 %id)
AA700503	parathyroid gland, parathyroid tumor	XPOT.a	3565 to 3970	409 to 4				406/409 (99 %)	0 diff (100 %id)
AA256044	germinal center B cell	XPOT.a	3575 to 3967	393 to 1				393/393 (100 %)	0 diff (100 %id)
AA233543	brain, neuroepithelial cells	XPOT.a	3583 to 3968	386 to 1				386/386 (100 %)	0 diff (100 %id)
N34775	melanocyte	XPOT.a	3585 to 3978	396 to 3				394/396 (99 %)	0 diff (100 %id)
AA903864	pooled germ cell tumors	XPOT.a	3591 to 3976	386 to 1				386/386 (100 %)	6 diff (98.5 %id)
BF056324	pooled	XPOT.a	3595 to 3974	383 to 4				380/383 (99 %)	0 diff (100 %id)
AI769333	pooled	XPOT.a	3596 to 3967	389 to 18		AAA		372/372 (100 %)	0 diff (100 %id)
H89552	cochlea, ear	XPOT.a	3601 to 3949	1 to 356				356/377 (94 %)	8 diff (97.9 %id)
AA708255	pineal gland	XPOT.a	3610 to 3968	359 to 1				359/359 (100 %)	3 diff (99.2 %id)
AW104846	ovary, tumor, 5 pooled (see description)	XPOT.a	3613 to 3967	355 to 1				355/355 (100 %)	0 diff (100 %id)
AW841832	colon_normal	XPOT.a	3614 to 3814	201 to 1				201/210 (95 %)	1 diff (99.6 %id)
R68486	placenta	XPOT.a	3620 to 3973	361 to 2				360/361 (99 %)	0 diff (100 %id)
AA010377	liver and spleen	XPOT.a	3620 to 3967	356 to 1				356/363 (98 %)	9 diff (97.6 %id)
CN417820	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.a	3624 to 4261	1 to 636				636/636 (100 %)	2 diff (99.7 %id)
AW352408	head_neck	XPOT.a	3630 to 3878	272 to 24				249/272 (91 %)	0 diff (100 %id)
BM052736	Islets of Langerhans, Pancreas	XPOT.a	3631 to 3967	355 to 18		AAA		338/338 (100 %)	5 diff (98.6 %id)
AW196739	adenocarcinoma, Pancreas	XPOT.a	3642 to 3970	332 to 4				329/333 (98 %)	0 diff (100 %id)
D79235	aorta	XPOT.a	3659 to 3915	1 to 265				265/265 (100 %)	10 diff (96.3 %id)
AI358370	poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus	XPOT.a	3663 to 3976	343 to 30		AAA		314/314 (100 %)	2 diff (99.4 %id)
BE003903	breast_normal	XPOT.a	3674 to 3842	1 to 170				170/170 (100 %)	13 diff (92.4 %id)
BM543312	embryonal carcinoma, cell line, testis	XPOT.a	3675 to 3970	294 to 3			Submitted on the opposite strand	292/310 (94 %)	0 diff (100 %id)
AW029473	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	XPOT.a	3678 to 3973	298 to 3				296/299 (98 %)	0 diff (100 %id)
AI566392	adenocarcinoma, Pancreas	XPOT.a	3682 to 3970	293 to 5				289/293 (98 %)	0 diff (100 %id)
BG165544	hypernephroma, cell line, Kidney	XPOT.a	3708 to 4478	1 to 764		AAA	Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base)	764/764 (100 %)	26 diff (96.6 %id)
N67848	melanocyte	XPOT.a	3709 to 3967	259 to 1				259/259 (100 %)	1 diff (99.7 %id)
F00337	leg muscle, skeletal muscle	XPOT.a	3712 to 3967	256 to 1				256/256 (100 %)	0 diff (100 %id)
AL120700	melanoma (MeWo cell line)	XPOT.a	3716 to 3967	1 to 252		AAA		252/252 (100 %)	0 diff (100 %id)
EC484763	Prostate	XPOT.a	3728 to 3849	1 to 119				119/120 (99 %)	9 diff (92.5 %id)
CN417819	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.a	3751 to 4337	1 to 589				589/589 (100 %)	4 diff (99.4 %id)
BE243411	leukopheresis	XPOT.a	3754 to 3974	222 to 1				222/222 (100 %)	10 diff (95.5 %id)
FN060526	breast carcinoma	XPOT.a	3756 to 3836	1 to 82				82/83 (98 %)	3 diff (96.4 %id)
CA432790	mixed	XPOT.a	3777 to 3975	217 to 19		AAA		199/199 (100 %)	0 diff (100 %id)
CX788705	human embryonic stem cells	XPOT.a	3780 to 4612	1 to 834		tiling clone,		834/834 (100 %)	1 diff (99.9 %id)
BQ775528	Bone, Human Chondrosarcoma Cell Line	XPOT.a	3791 to 4480	709 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	691/691 (100 %)	5 diff (99.3 %id)
DA736206		XPOT.a	3821 to 4490	2 to 670		capped		669/669 (100 %)	3 diff (99.6 %id)
AW976301		XPOT.a	3836 to 4479	644 to 1			Submitted on the opposite strand	644/647 (99 %)	6 diff (99.1 %id)
BM564749	eye, retinoblastoma	XPOT.a	3847 to 4687	1 to 855				855/1001 (85 %)	25 diff (97.6 %id)
EC515393	Prostate	XPOT.a	3853 to 3974	127 to 4				124/127 (97 %)	0 diff (100 %id)
BI253765	cervical carcinoma cell line, cervix	XPOT.a	3856 to 3967	1 to 112		AAA		112/112 (100 %)	0 diff (100 %id)
BE537983	cervix	XPOT.a	3869 to 3978	1 to 109				109/110 (99 %)	4 diff (96.4 %id)
CK821336	Pancreas, Purified pancreatic islet	XPOT.a	3892 to 4480	602 to 14		AAA	Submitted on the opposite strand	589/589 (100 %)	4 diff (99.4 %id)
AW069744	bone marrow stroma	XPOT.a	3925 to 4480	579 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	561/561 (100 %)	15 diff (97.4 %id)
BX472774		XPOT.a	3927 to 4480	574 to 21		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	554/554 (100 %)	3 diff (99.5 %id)
DA887189		XPOT.a	3951 to 4500	2 to 555		capped		554/554 (100 %)	5 diff (99.1 %id)
DA601887		XPOT.a	3959 to 4431	2 to 475		capped		474/474 (100 %)	5 diff (99.0 %id)
BM553797	duodenal adenocarcinoma, cell line, small intestine	XPOT.a	3988 to 4477	528 to 38			Submitted on the opposite strand	491/1417 (34 %)	0 diff (100 %id)
AK098081	trachea	XPOT.a	4007 to 6409	1 to 2404		tiling clone, available from FLJ,		2404/2404 (100 %)	10 diff (99.6 %id)
DB196379	trachea	XPOT.a	4008 to 4486	2 to 481		capped		480/480 (100 %)	6 diff (98.8 %id)
DA364396	subthalamic nucleus	XPOT.a	4023 to 4573	2 to 554		capped		553/553 (100 %)	4 diff (99.3 %id)
DA907018		XPOT.a	4036 to 4480	2 to 446		capped, AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	445/445 (100 %)	3 diff (99.4 %id)
AA668617	bone marrow stroma	XPOT.a	4055 to 4454	400 to 1				400/400 (100 %)	4 diff (99.0 %id)
AA749151	germinal center B cell	XPOT.a	4075 to 4489	414 to 1				414/414 (100 %)	5 diff (98.8 %id)
AW117831	esophagus, squamous cell carcinoma	XPOT.a	4128 to 4481	354 to 1				354/354 (100 %)	4 diff (98.9 %id)
DA885855		XPOT.a	4134 to 4686	2 to 556		capped		555/555 (100 %)	6 diff (99.0 %id)
CD357397	Blood vessels - aorta, basilar and artery	XPOT.a	4208 to 4936	1 to 743				743/771 (96 %)	29 diff (96.3 %id)
AL134198	brain	XPOT.a	4303 to 4678	40 to 416				377/416 (90 %)	9 diff (97.9 %id)
BQ946133	leiomyosarcoma, uterus	XPOT.a	4350 to 5264	1 to 926				926/927 (99 %)	19 diff (98.0 %id)
BE886036	leiomyosarcoma, uterus	XPOT.a	4426 to 4958	1 to 557				557/812 (68 %)	42 diff (94.9 %id)
BE884657	leiomyosarcoma, uterus	XPOT.a	4437 to 4942	1 to 541				541/744 (72 %)	64 diff (91.4 %id)
CF146723	CNCAP(3)T-225 cell line, Prostate	XPOT.a	4533 to 5193	8 to 668				661/668 (98 %)	9 diff (98.7 %id)
CF146748	CNCAP(3)T-225 cell line, Prostate	XPOT.a	4533 to 5166	8 to 640				633/640 (98 %)	6 diff (99.1 %id)
CF146848	CNCAP(3)T-225 cell line, Prostate	XPOT.a	4533 to 5180	8 to 655				648/655 (98 %)	6 diff (99.1 %id)
TI_154179235		XPOT.a	4533 to 5352	69 to 887				819/819 (100 %)	7 diff (99.2 %id)
TI_154179265		XPOT.a	4533 to 5385	76 to 927				852/855 (99 %)	17 diff (98.1 %id)
TI_154179377		XPOT.a	4533 to 5421	73 to 956				884/887 (99 %)	22 diff (97.6 %id)
BI027661	marrow	XPOT.a	4582 to 4937	359 to 1				359/359 (100 %)	16 diff (95.6 %id)
BG927836	cartilage	XPOT.a	4604 to 5182	78 to 656				579/656 (88 %)	6 diff (99.1 %id)
BI090120	cervix	XPOT.a	4665 to 5290	1 to 628				628/759 (82 %)	17 diff (97.8 %id)
BG255173	adenocarcinoma, cell line, Prostate	XPOT.a	4673 to 5447	1 to 775				775/996 (77 %)	18 diff (98.2 %id)
AA361677		XPOT.a	4688 to 4980	1 to 293				293/293 (100 %)	0 diff (100 %id)
BI086295	cervix	XPOT.a	4692 to 5565	1 to 877				877/877 (100 %)	24 diff (97.3 %id)
BE538787	cervix	XPOT.a	4771 to 5434	1 to 677				677/793 (85 %)	19 diff (97.7 %id)
BE887463	leiomyosarcoma, uterus	XPOT.a	4837 to 5512	1 to 682				682/742 (91 %)	16 diff (97.9 %id)
CN293830	embryonic stem cells, DMSO-treated H9 cellline	XPOT.a	4847 to 5234	1 to 388				388/388 (100 %)	0 diff (100 %id)
R12172	whole brain	XPOT.a	4899 to 5333	1 to 444				444/445 (99 %)	22 diff (95.1 %id)
F11364	brain, total brain	XPOT.a	5006 to 5303	1 to 298				298/298 (100 %)	0 diff (100 %id)
BE620332	large cell carcinoma, undifferentiated, lung	XPOT.a	5017 to 5616	1 to 601				601/812 (74 %)	16 diff (98.1 %id)
CN266503	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	5026 to 5586	564 to 2		tiling clone,	Submitted on the opposite strand	563/564 (99 %)	0 diff (100 %id)
AW877701	pnet	XPOT.a	5067 to 5491	1 to 426				426/426 (100 %)	7 diff (98.4 %id)
AW877607	pnet	XPOT.a	5077 to 5500	1 to 425				425/435 (97 %)	5 diff (98.9 %id)
AW877608	pnet	XPOT.a	5077 to 5491	1 to 416				416/416 (100 %)	1 diff (99.8 %id)
AW877766	pnet	XPOT.a	5077 to 5491	1 to 415				415/415 (100 %)	3 diff (99.3 %id)
AW877654	pnet	XPOT.a	5085 to 5491	21 to 425				405/425 (95 %)	6 diff (98.6 %id)
AW956871		XPOT.a	5091 to 5731	11 to 647		tiling clone,		637/649 (98 %)	15 diff (97.7 %id)
T08447		XPOT.a	5091 to 5450	1 to 360				360/360 (100 %)	0 diff (100 %id)
CD515326	White Matter	XPOT.a	5136 to 5974	1 to 843				843/843 (100 %)	14 diff (98.4 %id)
BF217677	brain, glioblastoma	XPOT.a	5293 to 5862	1 to 585				585/585 (100 %)	57 diff (90.3 %id)
CB956089	Pooled-Glandular	XPOT.a	5374 to 5874	1 to 506				506/933 (54 %)	21 diff (97.8 %id)
BE564610	bladder, carcinoma, cell line	XPOT.a	5409 to 6047	1 to 648				648/736 (88 %)	76 diff (89.7 %id)
BM687897	eye, Retina Foveal and Macular	XPOT.a	5435 to 6025	4 to 594		fully sequenced,	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	591/594 (99 %)	10 diff (98.4 %id)
EL955047	eyeball	XPOT.a	5465 to 6012	1 to 548				548/548 (100 %)	9 diff (98.4 %id)
TI_154126595		XPOT.a	5475 to 6409	993 to 79		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	915/1003 (91 %)	41 diff (96.0 %id)
CN277707	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.a	5500 to 6005	1 to 506		tiling clone,		506/506 (100 %)	15 diff (97.1 %id)
H89792	liver and spleen	XPOT.a	5509 to 5860	1 to 354				354/354 (100 %)	10 diff (97.2 %id)
BQ018985	lung, Metastatic Chondrosarcoma	XPOT.a	5605 to 6316	1 to 712			Submitted on the opposite strand	712/712 (100 %)	3 diff (99.6 %id)
AI267198	brain, frontal lobe (see description)	XPOT.a	5606 to 5928	43 to 365				323/365 (88 %)	6 diff (98.4 %id)
AA034283	uterus	XPOT.a	5625 to 5820	1 to 196				196/196 (100 %)	4 diff (98.0 %id)
BI092883	cervix	XPOT.a	5626 to 6446	822 to 1		tiling clone,	Submitted on the opposite strand	822/823 (99 %)	8 diff (99.1 %id)
TI_154127917		XPOT.a	5649 to 6409	834 to 81		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	754/928 (81 %)	18 diff (98.1 %id)
BQ773198	Chondrosarcoma Cell line	XPOT.a	5686 to 6409	737 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	722/722 (100 %)	3 diff (99.6 %id)
CA420037	Bone, Human Chondrosarcoma Cell Line	XPOT.a	5702 to 6406	722 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	704/704 (100 %)	1 diff (99.9 %id)
CA429923	Cell Line, Chondrosarcoma	XPOT.a	5703 to 6409	720 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	705/705 (100 %)	4 diff (99.5 %id)
CA416686	Chondrosarcoma Cell line	XPOT.a	5708 to 6409	716 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	701/702 (99 %)	3 diff (99.6 %id)
BU615338	Bone, Human Chondrosarcoma Cell Line	XPOT.a	5708 to 6409	717 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	702/703 (99 %)	0 diff (100 %id)
BM989569	lung, Metastatic Chondrosarcoma	XPOT.a	5709 to 6409	716 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	701/701 (100 %)	0 diff (100 %id)
BQ016086	lung, Metastatic Chondrosarcoma	XPOT.a	5712 to 6409	712 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	697/697 (100 %)	2 diff (99.8 %id)
CA311522	Human Lung Epithelial cells, lung	XPOT.a	5712 to 6406	713 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	695/695 (100 %)	0 diff (100 %id)
BI494298. matches multiple genes	cochlea, ear	XPOT.a	5729 to 6409	701 to 20		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene ferspor	682/682 (100 %)	1 diff (99.9 %id)
BQ026776	Chondrosarcoma, Left Pubic Bone	XPOT.a	5730 to 6413	701 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	683/683 (100 %)	2 diff (99.8 %id)
BI494977	cochlea, ear	XPOT.a	5741 to 6399	659 to 1				659/659 (100 %)	0 diff (100 %id)
AW242820	Kidney	XPOT.a	5770 to 6407	640 to 1				640/640 (100 %)	4 diff (99.4 %id)
AI743953	Kidney	XPOT.a	5800 to 6408	611 to 3				609/611 (99 %)	0 diff (100 %id)
TI_59392445		XPOT.a	5800 to 6408	54 to 661				608/842 (72 %)	8 diff (99.1 %id)
BM014427	breast, mammary adenocarcinoma, cell line	XPOT.a	5801 to 6408	1 to 607				607/636 (95 %)	7 diff (98.9 %id)
TI_154061268		XPOT.a	5825 to 6409	676 to 92		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	585/1014 (57 %)	0 diff (100 %id)
CA420496	Bone, Enchondroma cell line	XPOT.a	5825 to 6409	603 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	585/593 (98 %)	0 diff (100 %id)
DB368645		XPOT.a	5840 to 6409	573 to 1				573/574 (99 %)	14 diff (97.6 %id)
BM791044	stomach	XPOT.a	5851 to 6405	1 to 555				555/555 (100 %)	0 diff (100 %id)
AI912188	carcinoid, lung	XPOT.a	5861 to 6413	561 to 9				553/561 (98 %)	0 diff (100 %id)
DB348114	trachea	XPOT.a	5871 to 6409	539 to 1				539/539 (100 %)	0 diff (100 %id)
BG283999	adenocarcinoma, cell line, Prostate	XPOT.a	5914 to 6406	1 to 495		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	495/495 (100 %)	12 diff (97.6 %id)
AI268316	carcinoid, lung	XPOT.a	5915 to 6413	507 to 9				499/507 (98 %)	0 diff (100 %id)
BX103161	germinal center B cell	XPOT.a	5921 to 6409	1 to 490		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	490/490 (100 %)	1 diff (99.8 %id)
AA282592	germinal center B cell	XPOT.a	5921 to 6394	1 to 474		fully sequenced,		474/474 (100 %)	3 diff (99.4 %id)
BU537770	mixed (pool of 40 RNAs)	XPOT.a	5928 to 6415	1 to 488				488/512 (95 %)	8 diff (98.5 %id)
AI955322	brain, four pooled pituitary adenomas	XPOT.a	5942 to 6411	473 to 4				470/473 (99 %)	0 diff (100 %id)
AI138929	placenta	XPOT.a	5944 to 6411	468 to 1				468/468 (100 %)	0 diff (100 %id)
AI680802	carcinoid, lung	XPOT.a	5944 to 6408	465 to 1				465/465 (100 %)	3 diff (99.4 %id)
AA854852	parathyroid gland, parathyroid tumor	XPOT.a	5950 to 6406	477 to 21		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	457/457 (100 %)	0 diff (100 %id)
AI914144	carcinoid, lung	XPOT.a	5953 to 6408	455 to 1				455/455 (100 %)	1 diff (99.8 %id)
AI633670	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	XPOT.a	5954 to 6411	461 to 4				458/461 (99 %)	0 diff (100 %id)
AW340279	pooled	XPOT.a	5954 to 6411	459 to 2				458/459 (99 %)	0 diff (100 %id)
AI140173	lung	XPOT.a	5962 to 6408	447 to 1				447/447 (100 %)	0 diff (100 %id)
BF593191	Kidney	XPOT.a	5963 to 6410	448 to 1				448/448 (100 %)	0 diff (100 %id)
AW772041	Kidney	XPOT.a	5966 to 6409	469 to 26		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	444/444 (100 %)	1 diff (99.8 %id)
AI492764	lymph node, lymphoma, follicular mixed small and largecell	XPOT.a	5983 to 6410	428 to 1				428/428 (100 %)	0 diff (100 %id)
BM695944. matches multiple genes	eye, human retina	XPOT.a	5993 to 6406	1 to 414		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene ferspor	414/414 (100 %)	0 diff (100 %id)
BM662023	eye, Retina Foveal and Macular	XPOT.a	5995 to 6406	430 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	412/412 (100 %)	0 diff (100 %id)
AI985172	Kidney	XPOT.a	5997 to 6410	415 to 1				415/415 (100 %)	1 diff (99.8 %id)
AI123986	uterus	XPOT.a	6009 to 6414	405 to 1				405/405 (100 %)	1 diff (99.8 %id)
AW275107	pooled	XPOT.a	6014 to 6411	400 to 3				398/400 (99 %)	0 diff (100 %id)
BF887234	testis_normal	XPOT.a	6015 to 6248	1 to 235				235/248 (94 %)	5 diff (98.0 %id)
BF885934	testis_normal	XPOT.a	6019 to 6253	236 to 1			Submitted on the opposite strand	236/239 (98 %)	9 diff (96.3 %id)
AI360393	anaplastic oligodendroglioma, brain	XPOT.a	6023 to 6407	385 to 1				385/385 (100 %)	0 diff (100 %id)
AA032071	uterus	XPOT.a	6034 to 6406	374 to 1				374/375 (99 %)	3 diff (99.2 %id)
BF754097	colon	XPOT.a	6036 to 6245	1 to 208				208/217 (95 %)	6 diff (97.3 %id)
BU608499	Human Lung Epithelial cells, lung	XPOT.a	6062 to 6406	358 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	340/345 (98 %)	6 diff (98.3 %id)
T98664	liver and spleen	XPOT.a	6065 to 6381	327 to 1				327/392 (83 %)	12 diff (97.0 %id)
H89729	liver and spleen	XPOT.a	6085 to 6415	340 to 2				339/341 (99 %)	0 diff (100 %id)
AA636124	Ewing's sarcoma	XPOT.a	6089 to 6409	333 to 12		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	322/322 (100 %)	1 diff (99.7 %id)
AW001712	Kidney	XPOT.a	6094 to 6411	322 to 5				318/322 (98 %)	0 diff (100 %id)
CN310928	embryonic stem cells, cell lines H1, H7, andH9	XPOT.a	6110 to 6409	352 to 52		AAA	Submitted on the opposite strand	301/301 (100 %)	6 diff (98.1 %id)
F09024	brain, total brain	XPOT.a	6127 to 6409	283 to 1				283/283 (100 %)	0 diff (100 %id)
BP431261		XPOT.a	6152 to 6413	1 to 262		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	262/262 (100 %)	2 diff (99.3 %id)
AI799368	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	XPOT.a	6162 to 6409	261 to 14		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	248/248 (100 %)	0 diff (100 %id)
BG152981	head/neck, nasopharyngeal carcinoma	XPOT.a	6183 to 6411	44 to 272				229/273 (83 %)	6 diff (97.9 %id)
AA741091	germinal center B cell	XPOT.a	6212 to 6409	213 to 16		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	198/198 (100 %)	0 diff (100 %id)
CA433450	mixed	XPOT.a	6260 to 6406	165 to 19		AAA	Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base)	147/147 (100 %)	0 diff (100 %id)
AA282481	germinal center B cell	XPOT.a	6319 to 6413	95 to 1		fully sequenced,		95/95 (100 %)	2 diff (97.9 %id)
DA056937	cerebellum	XPOT.b	1 to 549	2 to 550		tiling clone, capped		549/549 (100 %)	1 diff (99.9 %id)
DB296659	cerebellum	XPOT.b	1884 to 2426	544 to 1		tiling clone,		544/544 (100 %)	1 diff (99.9 %id)
BF797238	lymph, lymphoma, cell line	XPOT.b	2120 to 2884	1 to 778		tiling clone,		778/976 (79 %)	30 diff (97.0 %id)
BM548191	brain, hippocampus	XPOT.b	2791 to 3599	1 to 815		tiling clone,		815/1144 (71 %)	31 diff (97.3 %id)
TI_154154450		XPOT.c	1 to 648	81 to 728	V200G C205W	tiling clone,		648/649 (99 %)	5 diff (99.3 %id)
BF345009	brain, glioblastoma with EGFR amplification	XPOT.c	428 to 1206	1 to 772		tiling clone,		770/987 (78 %)	34 diff (96.6 %id)
DB274805	uterus	XPOT.d	1 to 555	2 to 557	L49X A50G S51L V52C R53S ...	tiling clone, capped		556/556 (100 %)	2 diff (99.7 %id)
DB195290	trachea	XPOT.e	1 to 522	2 to 523	exact	tiling clone, capped		522/522 (100 %)	0 diff (100 %id)
CV573849	cornea, eye	XPOT.f	1 to 621	1 to 621	exact	tiling clone,		621/621 (100 %)	6 diff (99.1 %id)
DA766566	tongue	XPOT.g	1 to 567	2 to 569		tiling clone, capped		568/568 (100 %)	2 diff (99.7 %id)
DB066018	testis	XPOT.h	1 to 547	2 to 548	exact	tiling clone, capped		547/547 (100 %)	0 diff (100 %id)
CN409163	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	XPOT.i	1 to 376	25 to 401				377/401 (94 %)	6 diff (98.6 %id)
DA756575		XPOT.i	4 to 499	2 to 497		tiling clone, capped		496/496 (100 %)	1 diff (99.8 %id)
DB454385	testis	XPOT.i	6 to 470	1 to 465				465/465 (100 %)	3 diff (99.4 %id)
DA325675	hippocampus	XPOT.i	21 to 499	2 to 480		capped		479/479 (100 %)	2 diff (99.6 %id)
DA332341	hippocampus	XPOT.i	21 to 450	2 to 432		capped		429/431 (99 %)	2 diff (99.6 %id)
BU175601	large cell carcinoma, lung	XPOT.i	97 to 825	1 to 735	R60T	tiling clone,		735/921 (79 %)	19 diff (98.0 %id)
DA476145		XPOT.j	1 to 557	2 to 558	exact	tiling clone, capped		562/562 (100 %)	1 diff (99.9 %id)
DB136184	thymus	XPOT.j	89 to 531	2 to 445	exact	capped		442/444 (99 %)	1 diff (99.8 %id)
BE244323	leukopheresis	XPOT.j	103 to 533	1 to 431	exact	tiling clone,		431/431 (100 %)	4 diff (99.1 %id)
AI553821	anaplastic oligodendroglioma, brain	XPOT.j	157 to 488	396 to 65	exact	AAA		332/332 (100 %)	2 diff (99.4 %id)
AW296752		XPOT.k-u	1 to 312	331 to 16	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base)	314/314 (100 %)	0 diff (100 %id)
AL044817	testis	XPOT.k-u	304 to 539	1 to 237		tiling clone,		237/237 (100 %)	1 diff (99.6 %id)
BE764273	nervous_tumor	XPOT.l-u	1 to 335	334 to 1	L12Q	tiling clone,		334/337 (99 %)	9 diff (97.4 %id)
BE764322	nervous_tumor	XPOT.l-u	15 to 335	321 to 1	L12Q	tiling clone,		321/321 (100 %)	4 diff (98.8 %id)
CV383159	prostate_tumor	XPOT.m-u	1 to 310	7 to 317	Q4L W5N D6G E7*	tiling clone,		311/318 (97 %)	6 diff (98.2 %id)
DN912441		XPOT.n-u	1 to 264	1 to 263	exact	tiling clone,		263/264 (99 %)	2 diff (99.3 %id)
BF095596	uterus_tumor	XPOT.o-u	1 to 254	253 to 1	P2T L4S K14N L15W D16I ...	tiling clone,		253/260 (97 %)	9 diff (96.6 %id)
CN292390	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	XPOT.p-u	1 to 238	7 to 244	F26L Q28R	tiling clone,		238/244 (97 %)	6 diff (97.6 %id)
EH307804		XPOT.q	1 to 80	1 to 79	L21*	tiling clone,		79/79 (100 %)	1 diff (98.8 %id)
EH318450		XPOT.q	1 to 80	1 to 78	C14V Y15T D16I Y17I L18F ...			78/78 (100 %)	2 diff (97.5 %id)
AW673314. matches multiple genes	cervix	XPOTP1.a-u	1 to 455	1 to 454		tiling clone,	also hits gene XPOTP1	454/454 (100 %)	47 diff (89.7 %id)
AK308108	tongue	Gene XPOT, variant not shown					Suspected internal deletion, this clone was ignored
BF924211	nervous_tumor	Gene XPOT, variant not shown					Suspected internal deletion, this clone was ignored
AV696780	hepatocellular carcinoma	Gene XPOT, variant not shown					Suspected internal deletion, this clone was ignored
BP872381	embryonal kidney	Gene XPOT, variant not shown					This clone was ignored
AV726897	hypothalamus	Gene XPOT, variant not shown				AAA	Suspected internal deletion, this clone was ignored
BG492873	lung, mucoepidermoid carcinoma	Gene XPOT, variant not shown					Suspected internal deletion, this clone was ignored
BU184463	leiomyosarcoma, uterus	Gene XPOT, variant not shown					Suspected internal deletion, this clone was ignored
TI_153990588		Gene XPOT, variant not shown					This clone was ignored